Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
The "poison chair" treatment for multiple sclerosis.
Intrathecal interferon reduces exacerbations of multiple sclerosis.
Recent insights into the mechanism of action of glatiramer acetate.
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
Policy: NIH to balance sex in cell and animal studies.
Autoimmune myelopathies.
EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
Multiple sclerosis: Could Helicobacter pylori provide protection against multiple sclerosis?
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
Rituximab for relapsing-remitting multiple sclerosis.
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Voiding Dysfunction in Multiple Sclerosis.
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.

Pages